{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:39:35Z","timestamp":1783697975277,"version":"3.55.0"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>MiR-136 is abnormally expressed in many types of metastatic tumors and is closely associated with tumor cell proliferation, apoptosis, invasion, and metastasis, indicating its important role in tumor development and progression. This review summarizes current knowledge regarding miR-136\u2019s molecular mechanisms, functional roles, and impact on chemotherapy in different human cancers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A literature search was conducted in PubMed and Web of Science using \u201cmiR-136\u201d and \u201cmetastatic tumors\u201d as English keywords, and in CNKI and Wanfang databases using the same terms in Chinese. Studies related to miR-136 research in metastatic tumors and high-quality evidence from similar studies were included. Meta-analyses, dissertations, conference papers, low-quality articles, unavailable full-text articles, and republished articles were excluded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This review synthesizes the current understanding of miR-136\u2019s role in various cancers, including osteosarcoma, gastric cancer, gallbladder cancer, esophageal cancer, prostate cancer, colorectal cancer, breast cancer, glioma, and thyroid cancer. miR-136 acts as a tumor suppressor by targeting various genes, including MTDH, PTEN, MAP2K4, MUC1, LRH-1, MIEN1, RASAL2, CYR61, and KLF7. It influences multiple signaling pathways, including the ERK\/mitogen-activated protein kinase, Wnt\/\u03b2-catenin, Ha-Ras, PI3K\/Akt, Aurora-A kinase, nuclear factor-\u03baB, and JNK pathways. Furthermore, miR-136 is involved in chemoresistance by modulating ROCK1, PPP2R2A, and the miR-136-Notch3 signaling axis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MiR-136 demonstrates promising potential as a novel biomarker and therapeutic target in various human cancers. Further research is needed to fully elucidate its complex roles in cancer development, progression, and drug resistance, particularly regarding its potential in immunotherapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1555270","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:19:50Z","timestamp":1741065590000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Research and progress of microRNA-136 in metastatic tumors"],"prefix":"10.3389","volume":"15","author":[{"given":"Chenwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2006.12.007","article-title":"Repression of protein synthesis by miRNAs: how many mechanisms","volume":"17","author":"Pillai","year":"2007","journal-title":"Trends Cell Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.03.045","article-title":"Complexation of chol-DsiRNA in place of chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration","volume":"543","author":"Ambardekar","year":"2018","journal-title":"Int J Pharm"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-10-12","article-title":"Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells","volume":"10","author":"Tan","year":"2009","journal-title":"BMC Mol Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.5.5522","article-title":"RNA and transcriptional modulation of gene expression","volume":"7","author":"Hawkins","year":"2008","journal-title":"Cell Cycle (Georgetown Tex)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature07242","article-title":"The impact of microRNAs on protein output","volume":"455","author":"Baek","year":"2008","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1039\/c004401f","article-title":"Identifying targets of miR-143 using a SILAC-based proteomic approach","volume":"6","author":"Yang","year":"2010","journal-title":"Mol Biosyst"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3727\/096504018x15148192843443","article-title":"miR-136 inhibits malignant progression of hepatocellular carcinoma cells by targeting cyclooxygenase 2","volume":"26","author":"Jia","year":"2018","journal-title":"Oncol Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201811_16259","article-title":"MiR-136 triggers apoptosis in human gastric cancer cells by targeting AEG-1 and BCL2","volume":"22","author":"Yu","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10203","article-title":"Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma","volume":"17","author":"Chu","year":"2019","journal-title":"Oncol Letters"},{"key":"B15","article-title":"Clinical roles of miR-136-5p and its target metadherin in thyroid carcinoma","volume":"11","author":"Gao","year":"2019","journal-title":"Am J Trans Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3892\/or.2016.4767","article-title":"miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer","volume":"36","author":"Yan","year":"2016","journal-title":"Oncol Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/cbm-170970","article-title":"MicroRNA-136 functions as a tumor suppressor in osteosarcoma via regulating metadherin","volume":"22","author":"Guo","year":"2018","journal-title":"Cancer Biomarkers"},{"key":"B18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12957-020-01949-x","article-title":"MicroRNA-136-3p inhibits glioma tumorigenesis in vitro and in vivo by targeting KLF7","volume":"18","author":"Xu","year":"2020","journal-title":"World J Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.7848","article-title":"Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten\/Akt\/P-akt signaling pathway","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol Letters"},{"key":"B20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gene.2017.07.031","article-title":"MicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1\/Wnt signaling","volume":"628","author":"Yuan","year":"2017","journal-title":"Gene"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3640","article-title":"Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer","volume":"33","author":"Zhao","year":"2015","journal-title":"Oncol Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S321720","article-title":"Exosomal miR-136-5p derived from anlotinib-resistant NSCLC cells confers anlotinib resistance in non-small cell lung cancer through targeting PPP2R2A","volume":"16","author":"Gu","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11060-014-1535-x","article-title":"MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells","volume":"120","author":"Chen","year":"2014","journal-title":"J Neuro-Oncology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-014-0173-0","article-title":"MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1","volume":"9","author":"Wu","year":"2014","journal-title":"Diagn Pathology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3838","article-title":"Translational biology of osteosarcoma","volume":"14","author":"Kansara","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2017.08.030","article-title":"The effect of immune checkpoint inhibitors on lung metastases of osteosarcoma","volume":"52","author":"Shimizu","year":"2017","journal-title":"J Pediatr Surgery"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.01.008","article-title":"Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology","volume":"130","author":"Yoo","year":"2011","journal-title":"Pharmacol Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-09-1846","article-title":"Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes","volume":"69","author":"Sarkar","year":"2009","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002108","article-title":"Cancer statistics in china and united states, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(09)70343-2","article-title":"Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis","volume":"11","author":"Ueda","year":"2010","journal-title":"Lancet Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00004-10","article-title":"Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion","volume":"30","author":"Mukhopadhyay","year":"2010","journal-title":"Mol Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1086\/340026","article-title":"Protean PTEN: form and function","volume":"70","author":"Waite","year":"2002","journal-title":"Am J Hum Genet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0092-8674(00)81780-8","article-title":"Negative regulation of PKB\/Akt-dependenT cell survival by the tumor suppressor PTEN","volume":"95","author":"Stambolic","year":"1998","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2011.522","article-title":"Overexpression of DJ-1 and HSP90\u03b1, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers","volume":"3","author":"Lee","year":"2012","journal-title":"Oncol Letters"},{"key":"B35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00055.2019","article-title":"Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4","volume":"317","author":"Niu","year":"2019","journal-title":"Am J Physiol Gastrointestinal Liver Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13046-016-0318-y","article-title":"CCR7 mediates the TNF-\u03b1-induced lymphatic metastasis of gallbladder cancer through the \"ERK1\/2 - AP-1\" and \"JNK - AP-1\" pathways","volume":"35","author":"Hong","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2017.12.002","article-title":"Acetylation regulates the MKK4-JNK pathway in T cell receptor signaling","volume":"194","author":"Matsui","year":"2018","journal-title":"Immunol Letters"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/Journal.pone.0102289","article-title":"Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis","volume":"9","author":"Pavese","year":"2014","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-013-9387-0","article-title":"TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions","volume":"17","author":"Na","year":"2014","journal-title":"Angiogenesis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.2109","article-title":"Limonin induces apoptosis of HL-60 cells by inhibiting NQO1 activity","volume":"9","author":"Chen","year":"2021","journal-title":"Food Sci Nutr"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114375","article-title":"Design, synthesis, and evaluation of a novel series of mono-indolylbenzoquinones derivatives for the potential treatment of breast cancer","volume":"237","author":"Jia","year":"2022","journal-title":"Eur J Med Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16668","article-title":"Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by in vivo selection","volume":"8","author":"Okuda","year":"2017","journal-title":"Oncotarget"},{"key":"B44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.21037\/cco.2017.09.05","article-title":"Screening and prevention strategies and endoscopic management of early esophageal cancer","volume":"6","author":"Kim","year":"2017","journal-title":"Chin Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104278","article-title":"Up-regulation of microRNA-136 induces apoptosis and radiosensitivity of esophageal squamous cell carcinoma cells by inhibiting the expression of MUC1","volume":"110","author":"Huang","year":"2019","journal-title":"Exp Mol Pathology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.Cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2011.03.010","article-title":"Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice","volume":"81","author":"Giovannetti","year":"2012","journal-title":"Crit Rev Oncology\/Hematology"},{"key":"B48","article-title":"A comparative study of prostate cancer detection and management in china and in france","volume":"16","author":"Peyromaure","year":"2009","journal-title":"Can J Urology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.urology.2016.04.041","article-title":"Screening of differently expressed miRNA and mRNA in prostate cancer by integrated analysis of transcription data","volume":"94","author":"Sun","year":"2016","journal-title":"Urology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/srep25602","article-title":"miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.humpath.2011.08.003","article-title":"MAPK7 and MAP2K4 as prognostic markers in osteosarcoma","volume":"43","author":"Tesser-Gamba","year":"2012","journal-title":"Hum Pathology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1159\/000322644","article-title":"Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer","volume":"79","author":"Ishikawa","year":"2010","journal-title":"Oncology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207802","article-title":"Evidence of MKK4 pro-oncogenic activity in breast and pancreatic tumors","volume":"23","author":"Wang","year":"2004","journal-title":"Oncogene"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2016.08.043","article-title":"Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression","volume":"79","author":"Wan","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(21)00426-x","article-title":"The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection","volume":"7","author":"Patel","year":"2022","journal-title":"Lancet Gastroenterol Hepatology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/15384047.2015.1045693","article-title":"Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer","volume":"16","author":"Nadolny","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1677\/erc-10-0179","article-title":"The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion","volume":"17","author":"Chand","year":"2010","journal-title":"Endocrine-Related Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2004.03.008","article-title":"LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis","volume":"14","author":"Fayard","year":"2004","journal-title":"Trends Cell Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1500978112","article-title":"Silencing LRH-1 in colon cancer cell lines impairs proliferation and alters gene expression programs","volume":"112","author":"Bayrer","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv948","article-title":"LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner","volume":"44","author":"Kramer","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1159\/000066755","article-title":"Wnt\/beta-catenin\/tcf signaling: a critical pathway in gastrointestinal tumorigenesis","volume":"66","author":"Kolligs","year":"2002","journal-title":"Digestion"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1219592110","article-title":"Direct reprogramming by oncogenic ras and myc","volume":"110","author":"Ischenko","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B63","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.molcel.2004.07.009","article-title":"Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation","volume":"15","author":"Botrugno","year":"2004","journal-title":"Mol Cell"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.145","article-title":"Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells","volume":"28","author":"Dasgupta","year":"2009","journal-title":"Oncogene"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-06-0389","article-title":"C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer","volume":"5","author":"Evans","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/Journal.pone.0052292","article-title":"Solution structure of the oncogenic MIEN1 protein reveals a thioredoxin-like fold with a redox-active motif","volume":"7","author":"Hsu","year":"2012","journal-title":"PloS One"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2015.01057","article-title":"C35 is overexpressed in colorectal cancer and is associated tumor invasion and metastasis","volume":"9","author":"Dong","year":"2015","journal-title":"Bioscience Trends"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3620","article-title":"Disparities in breast cancer mortality trends between 30 european countries: retrospective trend analysis of WHO mortality database","volume":"341","author":"Autier","year":"2010","journal-title":"BMJ (Clinical Res ed)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.Cell.2007.05.018","article-title":"GEFs and GAPs: critical elements in the control of small g proteins","volume":"129","author":"Bos","year":"2007","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.08.004","article-title":"The RasGAP gene, RASAL2, is a tumor and metastasis suppressor","volume":"24","author":"McLaughlin","year":"2013","journal-title":"Cancer Cell"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e94022","DOI":"10.1371\/Journal.pone.0094022","article-title":"Identification of thyroid carcinoma related genes with mRMR and shortest path approaches","volume":"9","author":"Xu","year":"2014","journal-title":"PloS One"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.11.020","article-title":"RASAL2 promotes lung cancer metastasis through epithelial-mesenchymal transition","volume":"455","author":"Li","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1172\/jci76711","article-title":"RASAL2 activates RAC1 to promote triple-negative breast cancer progression","volume":"124","author":"Feng","year":"2014","journal-title":"J Clin Invest"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104350","article-title":"Overview of hereditary breast and ovarian cancer (HBOC) guidelines across europe","volume":"64","author":"Marmolejo","year":"2021","journal-title":"Eur J Med Genet"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.032","article-title":"Survival of adults with primary malignant brain tumours in europe; results of the EUROCARE-5 study","volume":"51","author":"Visser","year":"2015","journal-title":"Eur J Cancer (Oxford Engl 1990)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.04.120","article-title":"KLF7 promotes polyamine biosynthesis and glioma development through transcriptionally activating ASL","volume":"514","author":"Guan","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081817","article-title":"Current advances in thyroid cancer management. are we ready for the epidemic rise of diagnoses","volume":"18","author":"Rusinek","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/molecules190811586","article-title":"Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma","volume":"19","author":"Peng","year":"2014","journal-title":"Molecules (Basel Switzerland)"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.04.001","article-title":"Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a gynecol oncol group study","volume":"130","author":"Landrum","year":"2013","journal-title":"Gynecol Oncol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","author":"Berek","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: The first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg Chem"},{"key":"B86","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3892\/etm.2021.9748","article-title":"The miR-136-5p\/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells","volume":"21","author":"Yang","year":"2021","journal-title":"Exp Ther Med"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.11.017","article-title":"MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3","volume":"386","author":"Jeong","year":"2017","journal-title":"Cancer Lett"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.11.120","article-title":"MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling","volume":"495","author":"Ji","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2022.03.010","article-title":"miR-15a and miR-15b modulate natural killer and CD8(+)T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma","volume":"25","author":"Pathania","year":"2022","journal-title":"Mol Ther Oncol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5938688","article-title":"Anti-PD-L1 antibody enhances T cell immune responses and reduces resistance of breast cancer cells to radiotherapy","volume":"2022","author":"Guo","year":"2022","journal-title":"Oxid Med Cell Longev"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1555270\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:19:56Z","timestamp":1741065596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1555270\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":90,"alternative-id":["10.3389\/fonc.2025.1555270"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1555270","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"article-number":"1555270"}}